408304-11-0

Basic information

• Product Name: 4-{3-[4-(3,4-Dichloro-benzyl)-morpholin-2-ylmethyl]-ureidomethyl}-benzamide
• Synonyms: 4-{3-[4-(3,4-Dichloro-benzyl)-morpholin-2-ylmethyl]-ureidomethyl}-benzamide
• CAS NO: 408304-11-0
• Molecular Weight: 0
• Mol File: 408304-11-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 679.9°C at 760 mmHg
• Flash Point: 365°C
• Appearance: /
• Density: 1.359g/cm³
• Vapor Pressure: 2.04E-19mmHg at 25°C
• Refractive Index: 1.608
• CAS DataBase Reference: 4-{3-[4-(3,4-Dichloro-benzyl)-morpholin-2-ylmethyl]-ureidomethyl}-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{3-[4-(3,4-Dichloro-benzyl)-morpholin-2-ylmethyl]-ureidomethyl}-benzamide(408304-11-0)
• EPA Substance Registry System: 4-{3-[4-(3,4-Dichloro-benzyl)-morpholin-2-ylmethyl]-ureidomethyl}-benzamide(408304-11-0)

Safety Data

• Hazardous Substances Data: 408304-11-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C21H23Cl2N3O4/c22-18-6-3-15(9-19(18)23)12-26-7-8-30-17(13-26)11-25-21(29)24-10-14-1-4-16(5-2-14)20(27)28/h1-6,9,17H,7-8,10-13H2,(H,27,28)(H2,24,25,29)

Upstream product

• 408303-43-5 GW₇₆₆₉₉₄ 

Relevant articles and documents

NON PEPTIDIC HETEROBIVALENT MOLECULES FOR TREATING INFLAMMATORY DISEASES

The present invention relates to non peptidic, heterobivalent molecules (HBM) that are able to simultaneously bind a surface target protein as well as an endogenous or exogenous human antibody protein and induce immune effector function. More specifically, the present invention relates to agents capable of binding to a chemokine receptor and inducing the depletion of chemokine receptor positive subsets of pathogenic cells in a subject for use in the treatment and/or prevention of cancer, inflammatory, autoimmune and allergic disease.